# Kura Oncology, Inc. (KURA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Kura Oncology, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/KURA/mda/fy2025/): filed 2026-03-05; accession 0001193125-26-092567 (https://www.sec.gov/Archives/edgar/data/1422143/000119312526092567/kura-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/KURA/mda/fy2024/): filed 2025-02-28; accession 0000950170-25-029975 (https://www.sec.gov/Archives/edgar/data/1422143/000095017025029975/kura-20241231.htm)
- [FY 2023 MD&A](/company/KURA/mda/fy2023/): filed 2024-02-27; accession 0000950170-24-021094 (https://www.sec.gov/Archives/edgar/data/1422143/000095017024021094/kura-20231231.htm)
- [FY 2022 MD&A](/company/KURA/mda/fy2022/): filed 2023-02-23; accession 0000950170-23-004107 (https://www.sec.gov/Archives/edgar/data/1422143/000095017023004107/kura-20221231.htm)
- [FY 2021 MD&A](/company/KURA/mda/fy2021/): filed 2022-02-24; accession 0000950170-22-001967 (https://www.sec.gov/Archives/edgar/data/1422143/000095017022001967/kura-20211231.htm)

Back to /company/KURA/